Keith W. Ward

2016

In 2016, Keith W. Ward earned a total compensation of $2.5M as Chief Development Officer at REATA PHARMACEUTICALS, a 488% increase compared to previous year.

Compensation breakdown

Bonus$150,000
Option Awards$2,085,580
Salary$300,000
Total$2,535,580

Ward received $2.1M in option awards, accounting for 82% of the total pay in 2016.

Ward also received $150K in bonus and $300K in salary.

Rankings

In 2016, Keith W. Ward's compensation ranked 3,875th out of 14,075 executives tracked by ExecPay. In other words, Ward earned more than 72.5% of executives.

ClassificationRankingPercentile
All
3,875
out of 14,075
73rd
Division
Manufacturing
1,356
out of 5,489
75th
Major group
Chemicals And Allied Products
415
out of 1,895
78th
Industry group
Drugs
304
out of 1,538
80th
Industry
Pharmaceutical Preparations
239
out of 1,176
80th
Source: SEC filing on April 24, 2017.

Ward's colleagues

We found two more compensation records of executives who worked with Keith W. Ward at REATA PHARMACEUTICALS in 2016.

2016

J Huff

REATA PHARMACEUTICALS

Chief Executive Officer

2016

Colin Meyer

REATA PHARMACEUTICALS

Chief Medical Officer

News

In-depth

You may also like